Attention-deficit/hyperactivity disorder (ADHD) in the adult population is frequently
associated with comorbid psychiatric diseases that complicate its recognition, diagnosis and …

Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

Introduction Inadequate treatment response and emotional blunting are common challenges
with selective serotonin reuptake inhibitors/serotonin-noradrenaline reuptake inhibitors …

The benefits of walking in older age include improved cognitive health (eg, mental alertness,
improved memory functioning) and a reduced risk of stress, depression and dementia …

ADHD is a major burden in adulthood, where co-morbid conditions such as depression,
substance use disorder and obesity often dominate the clinical picture. ADHD has …

The Research Domain Criteria (RDoC) initiative provides a strategy for classifying
psychopathology based on behavioral dimensions and neurobiological measures …

309 Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and
anti- reward systems Mark S. Gold8, K Page 1 309 Molecular role of dopamine in anhedonia …

Major depressive disorder is an often chronic and recurring illness. Left untreated, major
depressive disorder may result in progressive alterations in brain morphometry and circuit …

Orexin peptides comprise two neuropeptides, orexin A and orexin B, that bind two G-protein
coupled receptors (GPCRs), orexin receptor 1 (OXR1) and orexin receptor 2 (OXR2) …

Abstract Major Depressive Disorder (MDD) and bipolar disorder (BD) are still under
recognized and undertreated, especially in primary care settings. One of the challenges …